NUMERO: #20240996

Título: OSTEONECROSIS OF THE JAW EVOLUTION IN PATIENTS WITH BREAST CANCER, WITH 3 YEARS OF FOLLOW-UP: REPORT OF A CASE.

Nome do Apresentador: Fernando Luiz ZANFERRARI

Categoria do Trabalho: Painel de caso clínico (PCC)

Área Temática: Oncologia

Resumo: Zelendronic acid is one of the therapeutic alternatives in patients with breast cancer, to inhibit bone resorption in patients with metastatic breast cancer lesions. This paper aims to present a clinical evolution of osteonecrosis of the jaw associated with the use of medication, with 3 years of follow-up. A 58-year-old Caucasian female patient, diagnosed with breast cancer in 2017, used zelendronic acid once a month for two years. After two years, she presented bone exposure in his jaw due to the use of a poorly adapted prosthesis. The surgical approach had to be maxillary bone removal. Patient with tomographic follow-up for 3 years. It shows us the relevance of Dental clinicians of dental monitoring before, during, and after starting these medications.

Autor 1:  Fernando Luiz ZANFERRARI

E-mail 1:  [email protected]

Autor 2:   Aaron Bensaul Trujillo Lopez

E-mail 2:  [email protected]

Autor 3 :  Jose Luis Dissenha

E-mail 3:  [email protected]

Autor 4:  Lara Feltraco

E-mail 4:  [email protected]

Autor 5:  Bruna Bernardino Silva

E-mail 5:  [email protected]

Autor 6:  Priscila Queiroz Mattos da Silva

E-mail 6:  [email protected]

Autor 7:  Laurindo Moacir Sassi

E-mail 7:  [email protected]